Search images on Google      Product Monograph

Active Ingredients:

• sodium polystyrene sulfonate, 1 G/G

DIN: 02026961

Dosage Form(s): POWDER FOR SUSPENSION

Route(s) of Administration: ORAL, RECTAL

Schedule: Prescription

Company: SANOFI-AVENTIS CANADA INC  –  official site

ATC:

• V03 - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO, Wiki)
• V03A - ALL OTHER THERAPEUTIC PRODUCTS (ATC, WHO)
• V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, WHO)
• V03AE01 - POLYSTYRENE SULPHONATE (WHO)

Reference brand drug: Kayexalate

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 454 GM

Pharmaceutical standard: USP

 

External Links for Kayexalate:

Search on Google

• Kayexalate side effects
• Kayexalate dosage
• sodium polystyrene sulfonate side effects
• sodium polystyrene sulfonate dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find kayexalate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.